A major prostate cancer decision is expected to reject offering screening tests to the wider male population

A three-year review by the UK National Screening Committee will today advise ministers if those most at risk should get routine testing. It is expected to reject offering the Prostate Specific Antigen (PSA) test more widely to two key groups known to be more likely to develop the disease. These are Black men and men with a family history of the disease.

However the recommendation is expected to say a minority of at-risk men - those known to have the BRCA gene mutation - should be invited for PSA tests.

It is the UK's most common cancer, with 63,000 cases and 12,000 deaths each year. But, unlike breast, bowel and lung cancer, no national screening programme exists.

That is becaus

See Full Page